Velan Capital Sells $4.1 Million Worth of Shares in Mineralys Therapeutics
Velan Capital Investment Management LP sold 140,000 shares of Mineralys Therapeutics (MLYS) for an estimated value of $4.1 million during the first quarter of 2026. The sale reduced its stake to 11,000 shares valued at approximately $300,000 as of quarter-end.
Tickers: $MLYS